A. de Meijere et al.
FULL PAPER
N-(1-Ethylpropyl)piperidine (3cq): From N-formylpiperidine (1c,
phenylmagnesium bromide (2m, 5 mmol) the amine 4dm was ob-
565 mg, 5 mmol) and ethylmagnesium bromide (2q, 11 mmol) the tained as a yellow oil (490 mg, 52%).[20]
amine 3cq was obtained as a yellow oil (272 mg, 35%).[19]
N-[1-(4-Fluorphenyl)ethyl]piperidine (4cp): From N-formylpiper-
idine (1c, 569 mg, 5 mmol), methylmagnesium chloride (5 mmol)
and 4-fluorophenylmagnesium bromide (2p, 5 mmol) the amine 4cp
was obtained as a reddish oil (450 mg, 43%). 1H NMR ([D6]-
N-Benzhydrylmorpholine (3dm): From N-formylmorpholine (1d,
575 mg, 5 mmol) and phenylmagnesium bromide (2n, 11 mmol) the
amine 3dm was obtained as a colorless solid (548 mg, 43%), m.p.
70 °C.[20]
3
DMSO): δ = 1.25 (d, JH,H = 6.8 Hz, 3 H), 1.33 (mc, 2 H), 1.46
3
(mc, 4 H), 2.29 (mc, 4 H), 3.42 (q, JH,H = 6.8 Hz, 1 H), 7.07–7.37
N-(4,4Ј-Dimethylbenzhydryl)morpholine (3dn): From N-formyl-
morpholine (1d, 575 mg, 5 mmol) and p-tolylmagnesium bromide
(2n, 11 mmol) the amine 3dn was obtained as a yellow solid
(m, 4 H) ppm. 13C NMR ([D6]DMSO): δ = 18.4 (CH3), 24.1 (CH2),
25.7 (CH2), 50.4 (CH2), 62.9 (CH), 114.4 (d, 2JC,F = 20.4 Hz, CH),
128.9 (d, 3JC,F = 8.3 Hz, CH), 139.6 (C), 161.4 (d, 1JC,F = 152.4 Hz,
1 C) ppm. MS (70 eV): m/z (%) = 207 (7) [M]+, 192 (100) [M –
CH3]+, 123 (11) [M – C5H10N]+, 112 (9) [M – C6H4F]+.
1
(630 mg, 45%), m.p. 63 °C. H NMR ([D6]DMSO): δ = 2.22 (s, 6
3
3
H), 2.24 (t, JH,H = 4.5 Hz, 4 H), 3.57 (t, JH,H = 4.6 Hz, 4 H),
4.16 (s, 1 H), 7.07 (d, 3JH,H = 7.9 Hz, 4 H), 7.27 (d, 3JH,H = 8.0 Hz,
4 H) ppm. 13C NMR ([D6]DMSO): δ = 20.4 (CH3), 52.1 (CH2),
66.1 (CH2), 74.8 (CH), 127.3 (CH), 128.8 (CH), 135.7 (C), 137.4
(C) ppm. MS (70 eV): m/z (%) = 281 (29) [M]+, 195 (100) [M –
C4H8NO]+, 190 (10) [M – C7H7]+. C19H23NO (281.4): calcd. C
81.10, H 8.24, N 4.98; found C 81.26, H 8.18, N 4.74.
N-(1-Methyl-2-phenyl)-N,N-dimethylamine (4ar): From DMF (1a,
365 mg, 5 mmol), methylmagnesium chloride (5 mmol) and benzyl-
magnesium chloride (2r, 5 mmol) the amine 4ar was obtained as a
colorless oil (250 mg, 31%).[23]
Supporting Information (see also the footnote on the first page of
this article): NMR spectra of tertiary sec-alkylamines.
N-(4,4Ј-Dimethoxybenzhydryl)morpholine (3do): From N-formyl-
morpholine (1d, 575 mg, 5 mmol) and 4-methoxyphenylmagnesium
bromide (2o, 11 mmol) the amine 3do was obtained as a yellow oil
Acknowledgments
(642 mg, 40%). 1H NMR ([D6]DMSO): δ = 2.25 (t, 3JH,H = 9.1 Hz,
3
4 H), 3.57 (mc, 4 H), 3.69 (s, 6 H), 4.14 (s, 1 H), 6.84 (d, JH,H
=
This work was supported by Merck KGaA, Darmstadt, and
KAdemCustomChem GmbH, Göttingen. The authors are grateful
to Stefan Beußhausen for technical support in preparing this manu-
script in its final form.
8.7 Hz, 4 H), 7.29 (d, JH,H = 8.7 Hz, 4 H) ppm. 13C NMR ([D6]-
DMSO): δ = 52.1 (CH2), 54.8 (CH3), 66.1 (CH2), 74.0 (CH), 113.6
(CH), 128.4 (CH), 134.5 (C), 157.9 (C) ppm. MS (70 eV): m/z (%)
= 311 (1) [M]+, 227 (100) [M – C4H8NO]+, 206 (2) [M – C7H7O]+.
3
N-(4,4Ј-Difluorobenzhydryl)morpholine (3dp): From N-formyl-
morpholine (1d, 575 mg, 5 mmol) and 4-fluorophenylmagnesium
bromide (2p, 11 mmol) the amine 3dp was obtained as a colorless
[1] R. F. Borch, M. D. Bernstein, H. D. Durst, J. Am. Chem. Soc.
1971, 93, 2897–2904.
[2] Y. C. Hwang, M. Chu, F. W. Fowler, J. Org. Chem. 1985, 50,
1
solid (588 mg, 41%), m.p. 75 °C. H NMR ([D6]DMSO): δ = 2.22
3885–3895.
3
3
(t, JH,H = 4.5 Hz, 4 H), 3.55 (t, JH,H = 4.5 Hz, 4 H), 4.29 (s, 1
[3] G. Eisele, G. Simchen, Synthesis 1978, 757–758.
[4] G. Wieland, G. Simchen, Liebigs Ann. Chem. 1985, 2178–2193.
[5] D. Seebach, M. Schiess, Helv. Chim. Acta 1982, 65, 2598–2602.
[6] O. Tomashenko, V. Sokolov, A. Tomashevskiy, A. de Meijere,
Synlett 2007, 652–654.
[7] A. Fürstner, A. Hupperts, J. Am. Chem. Soc. 1995, 117, 4468–
4475.
[8] A. Fürstner, N. Shi, J. Am. Chem. Soc. 1996, 118, 2533–2534.
[9] Preliminary comunication, see: H. A. Buchholz, U. Welz-Bier-
mann, V. Chaplinski A. de Meijere, German Offen. No. DE
19844194 (Sept. 26, 1998); Chem. Abstr. 2000, 132: 35337m.
[10] a) V. Chaplinski, A. de Meijere, Angew. Chem. 1996, 108, 491–
492; Angew. Chem. Int. Ed. Engl. 1996, 35, 413–414; b) V.
Chaplinski, H. Winsel, M. Kordes, A. de Meijere, Synlett 1997,
111–114.
[11] For reviews see: a) O. G. Kulinkovich, A. de Meijere, Chem.
Rev. 2000, 100, 2789–2834; b) A. de Meijere, S. I. Kozhushkov,
A. I. Savchenko in Titanium and Zirconium in Organic Synthe-
sis (Ed.: I. Marek), Wiley-VCH, Weinheim 2002, pp. 390–434;
c) A. de Meijere, S. I. Kozhushkov, A. I. Savchenko, J. Or-
ganomet. Chem. 2004, 689, 2033–2055.
H), 7.04–7.11 (m, 4 H), 7.38–7.43 (m, 4 H) ppm. 13C NMR ([D6]-
DMSO): δ = 51.9 (CH2), 66.1 (CH2), 73.3 (CH), 115.1 (d, JC,F
21.1 Hz, CH), 129.2 (d, JC,F = 8.3 Hz, CH), 138.1 (C), 160.9 (d,
1JC,F = 243.0 Hz, 1 C) ppm. MS (70 eV): m/z (%) = 289 (46) [M]+,
203 (100) [M – C4H8NO]+, 194 (10) [M – C6H4F]+. C17H17F2NO
(289.3): calcd. C 70.57, H 5.92, F 13.13; found C 70.75, H 6.01, F
13.10.
2
=
3
General Procedure for the Synthesis of Tertiary sec-Alkylamines 4:
To a solution of the respective N,N-dialkylformamide 1 (5 mmol) in
THF (40 mL) was added Me3SiCl (543 mg, 5 mmol) and Ti(OiPr)4
(48 mg, 0.17 mmol). After stirring for 10 min, solutions of
MeMgCl and the respective second Grignard reagent were added
simultanously at r.t. Stirring was continued for 1 h, then 10% aq.
NaOH (30 mL) was added. The mixture was filtered, and the fil-
trate was extracted with CH2Cl2 (3ϫ50 mL). The combined or-
ganic phases were dried (Na2SO4) and concentrated under reduced
pressure. The residue was distilled using a kugelrohr apparatus to
furnish the product.
[12] a) J. W. Sloan, W. R. Martin, R. Hook, J. Hernandez, J. Med.
Chem. 1985, 28, 1245–1251; b) C. A. Grand, B. L. Bruno, A.
de Vazquez, G. Amalia, P. Lufrano, O. Baldini, Argent. Acta
Farmaceutica Bonaerence 1984, 3, 29–45; c) J. L. Katz, G. A.
Ricaurte, J. Witkin, Psychopharmocology 1992, 107, 315–318;
d) H. Rommelspacher, Pharmocologie und Toxicologie (Ed.: E.
Oberdisse, E. Hackenthal, K. Kuschinsky), chapter 7, Springer,
Berlin, 1997, pp. 157–161; e) E. Mutschler in Arzneimittelwir-
kungen, vol. 7, Wissenschaftliche Verlagsgesellschaft, Stuttgart,
1996, p. 167.
N-(1-Phenylethyl)-N,N-dimethylamine (4am): From DMF (1a,
365 mg, 5 mmol), methylmagnesium chloride (5 mmol) and phenyl-
magnesium bromide (2m, 5 mmol) the amine 4am was obtained as
a yellow oil (440 mg, 60%).[21]
N-(1-Phenylethyl)piperidine (4cm): From N-formylpiperidine (1c,
565 mg, 5 mmol), methylmagnesium chloride (5 mmol) and phenyl-
magnesium bromide (2m, 5 mmol) the amine 4 cm was obtained as
a yellow oil (433 mg, 46%).[22]
[13] T. S. Stevens, J. Chem. Soc. 1930, 2107–2119.
N-(1-Phenylethyl)morpholine (4dm): From N-formylmorpholine
(1d, 575 mg, 5 mmol), methylmagnesium chloride (5 mmol) and
[14] M. Nishi, S. Tanimoto, M. Okano, R. Oda, Yuki Gosei Kagaku
Kuokaishi 1969, 27, 754–758; Chem. Abstr. 71, 101438v.
5110
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 5107–5111